C12Y 304/13009
Xaa-pro dipeptidase i.e. prolidase
Official title: Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase
C12Y304/13009 (Xaa-pro dipeptidase i.e. prolidase) appears on 9 US grants and 17 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 17
- Assignees
- 10
- Inventors
- 48
- Latest grant
- 14 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Flavour generation in food14 Nov 2023US 11,812,755 B2Societe des Produits Nestle S. A.
- Flavour generation in food1 Nov 2022US 11,484,036 B2Societe des Produits Nestle S. A.
- Method for prophylaxis and/or treatment of ErbB2 positive cancers31 Aug 2021US 11,103,563 B2Health Research, Inc.
- Method for prophylaxis or treatment of erbb1 positive cancers using a variant peptidase d with reduced activity19 Nov 2019US 10,478,477 B2Health Research, Inc.
- Method for prophylaxis and/or treatment of ErbB2 positive cancers18 Dec 2018US 10,155,028 B2Health Research, Inc.
- Systems and methods for producing collagen 7 compositions23 Jul 2026US 2026/0209315 A1Phoenix Tissue Repair, Inc.
- Combination of garadacimab and prolidase for cancer therapy26 Feb 2026US 2026/0055208 A1
- Depleting egfr and her2 overcomes resistance to egfr inhibitors in colorectal cancer9 Jan 2025US 2025/0009852 A1Health Research, Inc.
- Means and methods for detoxifying ochratoxin a24 Oct 2024US 2024/0352438 A1DSM Austria GmbH
- Method for prophylaxis and/or treatment of erbb2 positive cancers5 Sep 2024US 2024/0293518 A1Health Research, Inc.
Most cited
By later US patents